Literature DB >> 27995432

Investigation of Image Reconstruction Parameters of the Mediso nanoScan PC Small-Animal PET/CT Scanner for Two Different Positron Emitters Under NEMA NU 4-2008 Standards.

Anastasios Gaitanis1, George A Kastis2,3, Elena Vlastou4, Penelope Bouziotis3, Panayotis Verginis5, Constantinos D Anagnostopoulos4.   

Abstract

PURPOSE: The Tera-Tomo 3D image reconstruction algorithm (a version of OSEM), provided with the Mediso nanoScan® PC (PET8/2) small-animal positron emission tomograph (PET)/x-ray computed tomography (CT) scanner, has various parameter options such as total level of regularization, subsets, and iterations. Also, the acquisition time in PET plays an important role. This study aims to assess the performance of this new small-animal PET/CT scanner for different acquisition times and reconstruction parameters, for 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) and Ga-68, under the NEMA NU 4-2008 standards. PROCEDURES: Various image quality metrics were calculated for different realizations of [18F]FDG and Ga-68 filled image quality (IQ) phantoms.
RESULTS: [18F]FDG imaging produced improved images over Ga-68. The best compromise for the optimization of all image quality factors is achieved for at least 30 min acquisition and image reconstruction with 52 iteration updates combined with a high regularization level.
CONCLUSION: A high regularization level at 52 iteration updates and 30 min acquisition time were found to optimize most of the figures of merit investigated.

Entities:  

Keywords:  3D OSEM; Image quality; Mediso nanoScan; NEMA NU 4-2008; Small-animal PET/CT; Tera-Tomo 3D; Total level of regularization

Mesh:

Substances:

Year:  2017        PMID: 27995432     DOI: 10.1007/s11307-016-1035-9

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  18 in total

1.  Total variation norm for three-dimensional iterative reconstruction in limited view angle tomography.

Authors:  M Persson; D Bone; H Elmqvist
Journal:  Phys Med Biol       Date:  2001-03       Impact factor: 3.609

2.  Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging.

Authors:  Keiichi Magota; Naoki Kubo; Yuji Kuge; Ken-Ichi Nishijima; Songji Zhao; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-10       Impact factor: 9.236

3.  Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scanner.

Authors:  Tyler J Bradshaw; Martin J Voorbach; David R Reuter; Anthony M Giamis; Sarah R Mudd; John D Beaver
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

4.  NEMA NU 4-2008 comparison of preclinical PET imaging systems.

Authors:  Andrew L Goertzen; Qinan Bao; Mélanie Bergeron; Eric Blankemeyer; Stephan Blinder; Mario Cañadas; Arion F Chatziioannou; Katherine Dinelle; Esmat Elhami; Hans-Sonke Jans; Eduardo Lage; Roger Lecomte; Vesna Sossi; Suleman Surti; Yuan-Chuan Tai; Juan José Vaquero; Esther Vicente; Darin A Williams; Richard Laforest
Journal:  J Nucl Med       Date:  2012-06-14       Impact factor: 10.057

5.  Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner.

Authors:  Yuchuan Wang; Jurgen Seidel; Benjamin M W Tsui; Juan J Vaquero; Martin G Pomper
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057

6.  Development of a Novel Nonpeptidic (18)F-Labeled Radiotracer for in Vivo Imaging of Oxytocin Receptors with Positron Emission Tomography.

Authors:  Barbara Wenzel; Jan Mollitor; Winnie Deuther-Conrad; Sladjana Dukic-Stefanovic; Mathias Kranz; Chrysoula Vraka; Rodrigo Teodoro; Robert Günther; Cornelius K Donat; Friedrich-Alexander Ludwig; Steffen Fischer; Rene Smits; Wolfgang Wadsak; Markus Mitterhauser; Jörg Steinbach; Alexander Hoepping; Peter Brust
Journal:  J Med Chem       Date:  2016-02-03       Impact factor: 7.446

7.  In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers.

Authors:  Simone Maschauer; Susanne Gahr; Muktheshwar Gandesiri; Philipp Tripal; Regine Schneider-Stock; Torsten Kuwert; Matthias Ocker; Olaf Prante
Journal:  Nucl Med Biol       Date:  2015-10-20       Impact factor: 2.408

8.  Development of an ultrahigh resolution Si-PM based PET system for small animals.

Authors:  Seiichi Yamamoto; Hiroshi Watabe; Yasukazu Kanai; Tadashi Watabe; Katsuhiko Kato; Jun Hatazawa
Journal:  Phys Med Biol       Date:  2013-10-21       Impact factor: 3.609

9.  (18F)FDG-PET brain imaging during the micturition cycle in rats detects regions involved in bladder afferent signalling.

Authors:  Yves Deruyver; Roma Rietjens; Jan Franken; Silvia Pinto; Ann Van Santvoort; Cindy Casteels; Thomas Voets; Dirk De Ridder
Journal:  EJNMMI Res       Date:  2015-10-15       Impact factor: 3.138

10.  Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?

Authors:  Charline Lasnon; Audrey Emmanuelle Dugué; Mélanie Briand; Soizic Dutoit; Nicolas Aide
Journal:  EJNMMI Res       Date:  2015-11-05       Impact factor: 3.138

View more
  2 in total

1.  Evaluation of image quality with four positron emitters and three preclinical PET/CT systems.

Authors:  Jarmo Teuho; Leon Riehakainen; Aake Honkaniemi; Olli Moisio; Chunlei Han; Marko Tirri; Shihao Liu; Tove J Grönroos; Jie Liu; Lin Wan; Xiao Liang; Yiqing Ling; Yuexuan Hua; Anne Roivainen; Juhani Knuuti; Qingguo Xie; Mika Teräs; Nicola D'Ascenzo; Riku Klén
Journal:  EJNMMI Res       Date:  2020-12-10       Impact factor: 3.138

2.  Performance of nanoScan PET/CT and PET/MR for quantitative imaging of 18F and 89Zr as compared with ex vivo biodistribution in tumor-bearing mice.

Authors:  Marion Chomet; Maxime Schreurs; Ricardo Vos; Mariska Verlaan; Esther J Kooijman; Alex J Poot; Ronald Boellaard; Albert D Windhorst; Guus Ams van Dongen; Danielle J Vugts; Marc C Huisman; Wissam Beaino
Journal:  EJNMMI Res       Date:  2021-06-12       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.